UBXG vs GSUN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GSUN Captures Institutional Edge (2โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Golden Sun Health Technology Group Limited Class A Ordinary Shares (GSUN) driven by superior Valuation, Growth & Margin while UBXG counters with relative strength in Momentum & Technical. Fundamentally, UBXG trades at N/M Forward P/E with -87.6% operating margin (-32.6% YoY revenue) versus GSUN at N/M Forward P/E and -10.2% operating margin (+30.1% YoY). In options structure, UBXG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GSUN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | UBXG | GSUN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $9.2M | $1.3M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | 0.3x | Lower Multiple | GSUN |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -32.6% | +30.1% | Higher Growth | GSUN |
| Operating Margin (TTM) Profitability | -87.6% | -10.2% | Higher Margin | GSUN |
| Net Profit Margin Profitability | -55.1% | -9.8% | Higher Margin | GSUN |
| Return on Equity (ROE) Capital Efficiency | -46.6% | -247.2% | Higher ROE | UBXG |
| 52-Week Range Position Momentum | 38% ($0โ$13) | 1% ($0โ$2) | Stronger Trend | UBXG |
| Beta / 30D Volatility Risk Regime | 10.23ฮฒ ยท 225% Vol | 0.59ฮฒ ยท 59% Vol | Lower Realized Risk | GSUN |
| Unified Institutional Score Composite Signal | 48.9 / 100 (HOLD) | 40.3 / 100 (SELL) | Higher Composite | UBXG |